RxSight, Inc. (RXST) Form 8-K — Jul 15, 2026
$RXSTForm 8-KItems 5.02, 7.01, 9.01Filed Jul 15, 2026, 4:23 PM ET0001193125-26-304812Original filing
RxSight appointed Aziz Mottiwala as President and Chief Executive Officer, effective July 20, 2026, succeeding Ron Kurtz, M.D. Dr. Kurtz will transition to the role of Chief Medical Officer and resign from the Board of Directors, with Mottiwala filling the resulting vacancy as a Class II director. Mottiwala received an employment agreement with a base salary of $750,000 and a target bonus opportunity of 90%.
Key figures
- Kurtz Base Salary
- 740000
- Mottiwala RSUValue
- 12000000
- Mottiwala2026 Bonus
- 337500
- Kurtz Retention Bonus
- 370000
- Kurtz Transition RSUs
- 500000
- Mottiwala Base Salary
- 750000
- Mottiwala Option Value
- 2000000
- Inducement Plan Shares Reserved
- 3500000
- Mottiwala Inducement Award Value
- 14000000
Price after filing
1 day: 0.0%7 days: +2.7%30 days: +33.5%
Close on the filing date to close N calendar days later (from $5.25). Historical, not a forecast.
AI analysis
Red flags3 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.